Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals

Conclusion

Over the past three years, there has been a growing volume of scientific literature reporting adverse effects of exposure to COVID-19 mRNA gene therapies. Unvaccinated women have been sharing personal stories of adverse health effects after exposure to vaccinated individuals, such as heavier menstrual bleeding than usual early menses, and extended menstrual bleeding. This observational study found that women with no direct COVID-19 vaccine or SARS-CoV-2 exposure seemed to be having menstrual abnormalities similar to those reported by the vaccinated population. Our findings suggest possible indirect transmission of ingredients or products of the COVID-19 vaccines, presumably through shedding, from people who received one or more of the COVID-19 injections. Aside from the COVID-19 mRNA vaccines, several new mRNA-based vaccines are now in clinical trials. Our findings support the need for shedding studies for current and future gene therapy products, as detailed in the 2015 FDA guidance.

link